Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Self-Injury: early-phase trial registry

4 of 5 indexed Self-Injury trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Self-Injury: 5 US clinical trials tracked, 4 recruiting.

Self-Injury is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Rutgers, The State University of New Jersey, running 3 of these trials.

Enrollment posture brief

Registry condition self-injury

OPEN 4 | RECR 80% | LATE 0 | EARLY 1 | RANK #3391 | SPON 3

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Self-Injury (this)80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Self-Injury

Self-Injury lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Self-Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Self-Injury is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Self-Injury research.

    Rutgers, The State University of New Jersey accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Self-Injury trials plan to enrol fewer than 100 people.

    Median target enrolment is 30 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Self-Injury research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Self-Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CDT Behavioral
1 trials
Magnitude-hold condition Behavioral
1 trials
Magnitude-drop condition Behavioral
1 trials
Rate-hold condition Behavioral
1 trials
Rate-drop condition Behavioral
1 trials
Extinction-only condition Behavioral
1 trials
Propranolol Drug
1 trials
Research Units in Behavioral Intervention (RUBI) protocol Behavioral
1 trials

US sites by state

Facility locations filed on Self-Injury trials. A trial with sites in several states counts in each.

New Jersey 3 trials
New York 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Self-Injury page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Self-Injury condition card totals 5 registered trials; most-linked intervention CDT; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.